Literature DB >> 25986764

Prostate cancer: Intermediate risk: RT or ADT?

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25986764     DOI： 10.1038/nrurol.2015.117

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.

Authors:  Florence K Keane; Ming-Hui Chen; Danjie Zhang; Brian J Moran; Michelle H Braccioforte; Anthony V D'Amico
Journal:  Cancer       Date:  2015-04-29       Impact factor: 6.860
  1 in total
  1 in total

1.  Attenuation of Metabolic Syndrome by EPA/DHA Ethyl Esters in Testosterone-Deficient Obese Rats.

Authors:  Nikhil S Bhandarkar; Senthil Arun Kumar; Jarad Martin; Lindsay Brown; Sunil K Panchal
Journal:  Mar Drugs       Date:  2018-05-24       Impact factor: 5.118
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.